Showing results (2611-2620 of 2,835) with videos related to

Sort By:
Pageof 284
Nature Communications|May 14, 2024
A burden of proof study on alcohol consumption and ischemic heart diseaseSinclair Carr, Dana Bryazka, Susan A McLaughlin, et al.
The Journal of Clinical Investigation|April 25, 2024
Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancerXiaochao Tan, Shike Wang, Guan-Yu Xiao, et al.
Annals of the Rheumatic Diseases|October 5, 2022
Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reportsMichelle Petri, Helain Landy, Megan E B Clowse, et al.
Nature Chemical Biology|March 25, 2022
Systematic identification of biomarker-driven drug combinations to overcome resistanceMatthew G Rees, Lisa Brenan, Mariana do Carmo, et al.
Annals of Surgery|September 12, 2013
The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinomaAshleigh M Francis, Boris Sepesi, Arlene M Correa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2008
Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancerRuth L Katz, Tanweer M Zaidi, Ricardo L Fernandez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2020
Telomere Length, Traditional Risk Factors, Factors Related to Human Immunodeficiency Virus (HIV) and Coronary Artery Disease Events in Swiss Persons Living With HIVTanja Engel, Marieke Raffenberg, Isabella C Schoepf, et al.
The Journal of Allergy and Clinical Immunology|February 6, 2014
Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of diseaseAlex Poole, Cydney Urbanek, Celeste Eng, et al.
RMD Open|September 17, 2021
Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparisonHermine I Brunner, Carlos Abud-Mendoza, Masaaki Mori, et al.
Leukemia & Lymphoma|August 12, 2023
Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpressionEytan M Stein, Stephane de Botton, Thomas Cluzeau, et al.
Pageof 284